Luna Innovations Equity Ratio
Delisted·Sep 17, 2026
The Equity Ratio of Luna Innovations (LUNA) as of Nov 12, 2026 is 61.85 %. In the previous year, Equity Ratio was 62.90 % — a change of -1.67% (lower).
Get this data via API
Financial Data API
Equity Ratio
61.85 %
YoY
-1.67%
Last updated:
Equity Ratio of Luna Innovations is 2022 61.85 % . Equity Ratio of Luna Innovations was 2021 62.90 % . It decreases by -1.67% lower compared to the previous year.
The Luna Innovations Equity Ratio history
3 Years
10 Years
25 Years
Max
Equity Ratio
Date
Equity Ratio
Jan 1, 2015
63.49 USD
Jan 1, 2016
63.80 USD
Jan 1, 2017
74.80 USD
Jan 1, 2018
82.48 USD
Jan 1, 2019
77.98 USD
Jan 1, 2020
56.83 USD
Jan 1, 2021
62.90 USD
Jan 1, 2022
61.85 USD
| YEAR | Equity Ratio | YoY |
|---|---|---|
| 61.85 % | -1.67% | |
| 62.90 % | +10.70% | |
| 56.83 % | -27.13% | |
| 77.98 % | -5.46% | |
| 82.48 % | +10.26% | |
| 74.80 % | +17.24% | |
| 63.80 % | +0.50% | |
| 63.49 % | -7.85% | |
| 68.90 % | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Luna Innovations Stock analysis
What does Luna Innovations do? Luna Innovations Inc. is a Virginia-based company that develops and markets innovative technologies. The company was founded in 1990 and began as a pioneer in the field of fiber optic sensor technology in the 1990s. Over the years, Luna Innovations Inc. has expanded its business operations and now consists of three business segments: Advanced Optical Technology, Health Sciences, and Luna Labs. The Advanced Optical Technology segment includes the development and marketing of sensors and measurement devices used in various industries and applications. This includes fiber optic sensors for structural monitoring and optical measurement devices for material analysis. Luna Innovations' Health Sciences segment specializes in the development and marketing of technologies related to medicine and the life sciences. This includes diagnostic and analysis devices as well as instruments for clinical research. Luna Labs is the research and development arm of Luna Innovations Inc., focusing on exploring and developing new technologies and products, as well as collaborating with customers and partners to evaluate and implement new technologies. Luna Innovations Inc. offers products such as the OBR 5T-OTDR, an optical time-domain reflectometer for fiber optic signal analysis, the fiber-optic acoustic sensor (FOAS) for sound location and analysis, and InCyte, a platform for biological and medical research. The company has also announced a collaboration with NASA for the development of fiber optic sensors for spacecraft. Luna Innovations Inc. has received multiple awards for its innovative technology and industry leadership. Luna Innovations Inc. exemplifies a company that focuses on the development and marketing of technologies that can be applied in various industries and applications. With its experience in fiber optic sensor technology, the company has expanded its offerings and developed innovative products for use in the medical and life sciences fields, as well as for structural monitoring. Luna Innovations is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Luna Innovations stock
Equity Ratio of Luna Innovations is 61.85 % in 2022.
Equity Ratio of Luna Innovations changed from 62.90 % to 61.85 %, representing a -1.67% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Equity Ratio Luna Innovations since 2006 – with annual values, charts, and detailed analysis.
The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.
A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's Luna Innovations with sector peers and the industry average to assess whether it is attractive.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Leverage — Luna Innovations
All Key Metrics — Luna Innovations
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth